SCHEMBL13014249

SCHEMBL13014249

CCOC(=O)C1=C(C)Nc2c(c(N3CCN(C(c4ccc(F)cc4)c4ccc(F)cc4)CC3)nc(=O)n2CCOC)C1c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPT P10636 13/20 0.47
LMNA P02545 4/20 0.43
ADORA3 P0DMS8 1/20 0.42
TP53 P04637 1/20 0.40
ACHE P22303 2/20 0.40
POLB P06746 1/20 0.40
BRD4 O60885 1/20 0.39
BRD2 P25440 1/20 0.39
BRD3 Q15059 1/20 0.39
BRDT Q58F21 1/20 0.39
CACNA1F O60840 1/20 0.38
CACNA1D Q01668 1/20 0.38
CACNA1S Q13698 1/20 0.38
CACNA1C Q13936 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13014019 0.95 ADORA3 (0.43) MAPTLMNAADORA3ACHEBRD4
SCHEMBL13014069 0.92 ADORA3 (0.41) MAPTLMNAADORA3ACHEBRD4
SCHEMBL13013474 0.91 ADORA3 (0.43) MAPTADORA3ACHECACNA1FCACNA1D
SCHEMBL13014462 0.91 ADORA3 (0.40) MAPTLMNAADORA3ACHEBRD4
SCHEMBL13014018 0.91 ACHE (0.40) MAPTLMNAADORA3ACHEBRD4
SCHEMBL13014277 0.90 OPRD1 (0.45) MAPTLMNAADORA3ACHEBRD4
SCHEMBL13013581 0.90 MAPT (0.45) MAPTLMNATP53POLBKDM4E
SCHEMBL13014246 0.88 ADORA3 (0.42) MAPTADORA3ACHEBRD4BRD2
SCHEMBL13013471 0.88 ADORA3 (0.41) MAPTADORA3ACHEBRD4BRD2
SCHEMBL13014287 0.85 ADORA3 (0.44) MAPTADORA3ACHECACNA1FCACNA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010149786-A1 PYRIDO [2, 3-D] PYRIMIDINES AS WNT ANTAGONISTS FOR TREATMENT OF CANCER AND ARTHRITIS DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) 2010-12-29 WO disclosed